According to a market report by Lucintel, the future of the global medication adherence market looks promising with opportunities in the cardiovascular, central nervous system, diabetes, oncology, gastrointestinal, and musculoskeletal markets. The global medication adherence market is expected to reach an estimated $6 billion by 2030 with a CAGR of 12.4% from 2024 to 2030. The major drivers for this market are growing demand for mhealth technology, rising chronic disease, and increasing demand for personalized healthcare.
A more than 150–page report is developed to understand Trends,
opportunity and forecast in medication adherence market to 2030 by type
(hardware centric and software centric), medication (cardiovascular, central
nervous system, diabetes, oncology, gastrointestinal, musculoskeletal, and
others), and region (North America, Europe, Asia Pacific, and the Rest of the
World).
In this market, hardware centric and software centric are the major
segments of medication adherence market by type. Lucintel forecasts that
software centric will remain the larger segment over the forecast period due to
growing demand for software in medication adherence.
Within this market, cardiovascular is expected to witness the highest
growth.
Download sample by clicking on medication
adherence market
North America will remain the largest region over the forecast period due
to surge in aging population and rising incidence of chronic diseases in the
region.
AdhereTech, McKesson, Omnicell, and Medminder Systems are the major
suppliers in the medication adherence market.
This unique research report will enable you to make confident business
decisions in this globally competitive marketplace. For a detailed table of
contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth
through game
changer ideas and robust market & unmet
needs analysis. We are based in Dallas, TX and have
been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in
several publications like the Wall Street Journal, ZACKS, and the Financial
Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest
Publications
Concentrated
Nitric Acid Market in Canada
Dicyandiamide
Market in Canada
No comments:
Post a Comment